在PI3K突变转移的转移性乳腺母细胞瘤中,用Copanlisib治疗的持续性疾病回归:一个病例报告
Meghan M Lynch1, Pedro Hermida-Viveiros1, Sean Stencel1
1Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, USA.
Rare tumors
|January 10, 2025
概括
转移性母细胞瘤 (METAM) 是一种罕见的癌症. 向治疗的可潘利西布在患有PIK3CA突变的患者中显示出部分反应,为患者提供了新的治疗选择.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
背景情况:
- 骨髓母细胞瘤是一种罕见的,局部具有攻击性的瘤.
- 转移性乳腺母细胞瘤 (METAM) 是一种极为罕见的变体,在初级和转移性部位都有良性组织学.
相关概念视频
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K